SEC Form 4 · accession 0001273636-18-000081
APPLIED GENETIC TECHNOLOGIES CORP · AGTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark S Shearman
Officer — Chief Scientific Officer
Period of report
Dec 14, 2018
Accepted (ET)
Dec 18, 2018 · 7:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001273636
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 14, 2018 | S | 3,000 | $3.3509 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $3.35 to $3.36, inclusive. The reporting person undertakes to provide to Applied Genetic Technologies Corporation ("AGTC"), any security holder of AGTC, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.